Comera Life Sciences Holdings, Inc. (CMRA)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: May 9, 2025

CMRA Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2022 FY 2021 FY 2020
Period Ending
Dec '22 Dec '21 Dec '20
Cash & Equivalents
0.456.510.16
Cash & Short-Term Investments
0.456.510.16
Cash Growth
-93.14%4088.55%-
Accounts Receivable
0.030.090.11
Other Receivables
-0.140.01
Receivables
0.030.220.12
Prepaid Expenses
0.91-0.01
Restricted Cash
1.51--
Other Current Assets
0.160.050.03
Total Current Assets
3.066.780.31
Property, Plant & Equipment
0.570.550.18
Other Long-Term Assets
0.090.080.06
Total Assets
3.737.420.55
Accounts Payable
1.460.420.1
Accrued Expenses
1.070.50.11
Short-Term Debt
0.46--
Current Portion of Leases
0.20.12-
Current Unearned Revenue
0.14-0.03
Other Current Liabilities
1.730.010
Total Current Liabilities
5.061.050.23
Long-Term Debt
--0.16
Long-Term Leases
0.120.2-
Other Long-Term Liabilities
0.28--
Total Liabilities
5.461.250.39
Common Stock
0010.68
Additional Paid-In Capital
28.662.210.92
Retained Earnings
-34.9-16.9-11.45
Total Common Equity
-6.25-14.690.15
Shareholders' Equity
-1.736.170.15
Total Liabilities & Equity
3.737.420.55
Total Debt
0.780.320.16
Net Cash (Debt)
-0.336.19-0.01
Net Cash Per Share
-0.032.05-0.00
Filing Date Shares Outstanding
22.30.411.05
Total Common Shares Outstanding
16.710.411.05
Working Capital
-25.740.08
Book Value Per Share
-0.37-36.720.01
Tangible Book Value
-6.25-14.690.15
Tangible Book Value Per Share
-0.37-36.720.01
Machinery
0.660.620.48
Construction In Progress
0.09--
Leasehold Improvements
0.010.020.01
Source: S&P Global Market Intelligence. Standard template. Financial Sources.